Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Canada: Supreme completes sale with Emerald Health Botanicals

Supreme Pharmaceuticals announces its wholly owned subsidiary, 7ACRES, has completed a sale of dried cannabis to Emerald Health Botanicals, a wholly owned subsidiary of Emerald Health Therapeutics. Emerald is a Canadian Licensed Producer with a focus on advancing the science of medical cannabis through a deep commitment to research. All cannabis procured from 7ACRES by Emerald will be re-sold with a producer’s mark specifying the cannabis as “SunGrown by 7ACRES”.

“Emerald’s team has a depth of experience in life sciences and product development which is complementary to our focus on scaled cultivation. We see this transaction as the first step in building an ongoing relationship where each party can focus on its core competencies to develop competitive advantage,” stated John Fowler, CEO.

For more information:
Supreme Pharmaceuticals
202 – 20 De Boers Dr, Toronto ON
M3J 0H1
Phone: (416) 630-7272
info@supreme.ca
www.supreme.ca
Publication date: